Novel Gene Therapy Wows for BCG-Unresponsive Bladder Cancer Novel Gene Therapy Wows for BCG-Unresponsive Bladder Cancer

A novel gene therapy for BCG-unresponsive NMIBC, nadofaragene firadenovec, is being suggested as a"new gold standard" for these patients.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news